A
Price
$141.64
Change
+$2.94 (+2.12%)
Updated
Oct 3 closing price
Capitalization
40.16B
57 days until earnings call
STVN
Price
$25.98
Change
-$0.42 (-1.59%)
Updated
Oct 3 closing price
Capitalization
7.09B
37 days until earnings call
Interact to see
Advertisement

A vs STVN

Header iconA vs STVN Comparison
Open Charts A vs STVNBanner chart's image
Agilent Technologies
Price$141.64
Change+$2.94 (+2.12%)
Volume$2.35M
Capitalization40.16B
Stevanato Group SpA
Price$25.98
Change-$0.42 (-1.59%)
Volume$253.45K
Capitalization7.09B
A vs STVN Comparison Chart in %
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. STVN commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and STVN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (A: $141.64 vs. STVN: $25.98)
Brand notoriety: A and STVN are both not notable
A represents the Medical Specialties, while STVN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 140% vs. STVN: 63%
Market capitalization -- A: $40.16B vs. STVN: $7.09B
A [@Medical Specialties] is valued at $40.16B. STVN’s [@Pharmaceuticals: Other] market capitalization is $7.09B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.16B to $0. The average market capitalization across the [@Medical Specialties] industry is $11.61B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileSTVN’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • STVN’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than STVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while STVN’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 4 bearish.
  • STVN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, STVN is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а +15.02% price change this week, while STVN (@Pharmaceuticals: Other) price change was +1.25% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.32%. For the same industry, the average monthly price growth was +8.33%, and the average quarterly price growth was +36.25%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.63%. For the same industry, the average monthly price growth was +2.89%, and the average quarterly price growth was +20.22%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

STVN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical Specialties (+3.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+4.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($40.2B) has a higher market cap than STVN($7.09B). STVN has higher P/E ratio than A: STVN (45.91) vs A (32.41). STVN YTD gains are higher at: 19.229 vs. A (6.093). A has higher annual earnings (EBITDA): 1.8B vs. STVN (199M). STVN has less debt than A: STVN (418M) vs A (3.41B). A has higher revenues than STVN: A (6.79B) vs STVN (1.15B).
ASTVNA / STVN
Capitalization40.2B7.09B567%
EBITDA1.8B199M903%
Gain YTD6.09319.22932%
P/E Ratio32.4145.9171%
Revenue6.79B1.15B593%
Total CashN/A106M-
Total Debt3.41B418M816%
FUNDAMENTALS RATINGS
A: Fundamental Ratings
A
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASTVN
RSI
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
60%
Bearish Trend 21 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TGLR35.720.10
+0.29%
LAFFER|TENGLER Equity Income ETF
IYRI50.470.12
+0.24%
NEOS Real Estate High Income ETF
BSJS22.08-0.02
-0.09%
Invesco BulletShares 2028 HY Corp Bd ETF
PAI12.84-0.05
-0.39%
Western Asset Investment Grade Income Fund
TECL127.81-2.19
-1.68%
Direxion Daily Technology Bull 3X ETF